"Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women
Launched by PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE · Dec 1, 2022
Trial Information
Current as of January 22, 2025
Unknown status
Keywords
ClinConnect Summary
Background
Chile has a high prevalence of postpartum depression and a significant treatment gap. Some barriers to postpartum depression care uncover the need for more easily accessible and lower-cost interventions. Chile's high utilization of digital technologies across all social strata and the increased use of pregnancy and parenting apps open the possibility of delivering interventions through mobile devices. Cognitive-behavioral internet-based interventions have proven to be effective in reducing symptoms of depression in high-income countries. However, in Chile, this is an underdevelo...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- Women will be included if they:
- • have a \< 6-month-old baby,
- • have a PHQ-9 (Kroenke et al., 2001; Diez-Quevedo et al., 2001) score ≥ 5 points,
- • have minor or major depression according to the Mini-International Neuropsychiatric Interview (MINI: Sheehan et al., 1999; Ferrando et al., 2000),
- • are at least 18 years old,
- • are Chilean residents,
- • are fluent in written and spoken Spanish,
- • self-report ownership of a smartphone, and
- • self-report regular access to the internet.
- • Minor depression will be defined as the presence of two to four concurrent symptoms of depressive disorder (one of which is depressed mood or anhedonia) present most or all the time for at least two weeks, with symptoms causing dysfunction and negative impact on the individual's life (American Psychiatric Association, 2013). Major depression will be defined as the presence of five or more concurrent symptoms of depressive disorder (one of which is depressed mood or anhedonia) present most or all the time for at least two weeks, with symptoms causing dysfunction and a negative impact on the individual's life (American Psychiatric Association, 2013).
- Exclusion Criteria:
- • Participants exclusion criteria will be the following: illiteracy, risk of suicide, alcohol or substance abuse, bipolar disorder, and psychotic disorder.
About Pontificia Universidad Catolica De Chile
Pontificia Universidad Católica de Chile is a prestigious academic institution renowned for its commitment to excellence in education, research, and healthcare. As a clinical trial sponsor, the university leverages its extensive expertise in medical sciences to advance innovative research initiatives aimed at improving patient outcomes. With a strong emphasis on ethical standards and scientific rigor, the institution collaborates with multidisciplinary teams to conduct high-quality clinical trials that contribute to the advancement of medical knowledge and the development of effective therapeutic interventions. Its dedication to fostering a culture of inquiry and community engagement positions Pontificia Universidad Católica de Chile as a leader in the field of clinical research in Latin America.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials